Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04898634
Title A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | FRA | ESP

Facility Status City State Zip Country Details
Columbia University Medical Center Herbert Irving Pavilion RECRUITING New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
University of Washington RECRUITING Seattle Washington 98195-9472 United States Details
Centre Leon Berard RECRUITING Lyon Cedex 8 69373 France Details
APHM Hopital Timone RECRUITING Marseille 13005 France Details
Institut Gustave Roussy RECRUITING Villejuif 94800 France Details
Antoni van Leeuwenhoek COMPLETED Amsterdam 1066 CX Netherlands Details
Erasmus MC RECRUITING Rotterdam 3015 GD Netherlands Details
Hosp Univ Fund Jimenez Diaz RECRUITING Madrid 28040 Spain Details
Hosp Univ Hm Sanchinarro RECRUITING Madrid 28050 Spain Details
Hosp Virgen de La Victoria RECRUITING Málaga 29010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field